Global Pharmaceutical Contract Manufacturing Market Demand, Price, size and share 2017


Orbis Research Present’s Global Pharmaceutical Contract Manufacturing Market By Type (Active Pharmaceutical Ingredient manufacturing, Finished Dosage Formulation Development and Manufacturing, Secondary Market), Geography, Trends, Forecasts (2017-2022).


Contract manufacturing market is witnessing a high growth, as the pharmaceutical companies are focusing more on R & D of the drugs rather than manufacturing the formulated drug to stay competitive in the market. The global pharmaceutical contract manufacturing market was valued at USD 58 billion in 2016 and is expected to reach USD 90.26 billion by 2022, at a CAGR of 7.64% over the forecast period 2017 – 2022.

Overview of the Current Pharmaceutical Contract Manufacturing Industry

Companies in the upstream industry are undergoing restructuring so as to focus more on R & D, while stringent regulations on the pharmaceutical industry are compelling the companies to outsource manufacturing of drugs to contract manufacturers and focus on their core business processes. Pharmaceutical companies are increasingly relying on contract manufacturing, research, and packaging services, to fulfill their basic needs and specialized competencies.

The market for global pharmaceutical contract manufacturing by type has been broadly segmented into –

Active pharmaceutical ingredient (API) manufacturing m

Finished Dosage Formulation (FDF) development & manufacturing (sub-segmented further into solid dose formulation, liquid dose formulation & injectable dose formulation)

Secondary market

By dose formulation type, solid dose formulation constituted more than 40% of the overall pharmaceutical contract manufacturing market in the year 2014, attributing to lower costs of manufacturing, patent compliance and ease of maintenance. The segment is expected to grow at a CAGR of 3.66% over the forecast period, while injectable dose segment, will register highest CAGR of 12.37% over the next five years.

The global pharmaceutical contract manufacturing market has been geographically segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Get a PDF Sample of Global Pharmaceutical Contract Manufacturing Market Report at:  

In 2014, the United States was a major market for contract pharmaceutical manufacturing. India is estimated to be the fastest growing market owing to its cost competitiveness and quality manufacturing capabilities.

Factors driving the Pharmaceutical Market-

  • Growing innovative drugs
  • Increasing investments in R & D
  • Pharmaceutical companies opting for less number of vendors to avail the volume advantage and at the same time reduce logistics costs.
  • Need for minimizing costs and reducing the product development time, without compromising on efficiency or production capability.

Restraints of the Pharmaceutical Market-

  • Some of the key impediments hindering the growth of the market are –
  • In-house packaging
  • Capacity utilization issues affecting the profitability of contract manufacturing organizations (CMOs)
  • Increasing lead time & logistics costs
  • Opportunities of the Pharmaceutical Market-
  • Huge demand for next-generation biological therapies has opened a gateway of opportunities for pharmaceutical vendors/manufacturers across the globe.

Some of the major companies mentioned in the report are –

  • Aenova
  • Catalent
  • Famar
  • Haupt Pharma
  • Jubilant
  • Pfizer Central Source
  • Recipharm
  • Vetter

Place a Purchase Order for this Report at:   

Key Deliverables in the Study

  • Market analysis for the global pharmaceutical contract manufacturing market, with region specific assessments and competition analysis on global and regional scales.
  • Market definition along with the identification of key drivers and restraints.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their market share.
  • Identification and analysis of the macro and micro factors that affect the global pharmaceutical contract manufacturing market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
  • A wide-ranging knowledge and insight about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
  • Insights into the major countries/regions where this industry is growing and also identify the regions that are still untapped.

Major Points Covered in Global Pharmaceutical Contract Manufacturing Market Report:

  • Introduction
  • Research Methodology
  • Executive Summary
  • Market Dynamics
  • Technology Snapshot
  • Global Pharmaceutical Contract Manufacturing Market Segmentation – By Type
  • Pharma CMO Market -Segmented by geography
  • Investment Analysis
  • Future of Pharmaceutical Contract Manufacturing Market

About Us:

Orbis Research ( is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn:

%d bloggers like this: